Pharmaceutical Executive-05-01-2016

Pharmaceutical Executive

2016 Brand of the Year: Cancer Standout Opdivo

May 20, 2016

Features

36

5

Pharm Exec’s 10th annual Brand of the Year is Bristol-Myers Squibb’s Opdivo, which has raced into the lead position in the treatment-shifting immuno-oncology space behind launches in three key cancers-melanoma, lung, and renal.

Pharm Exec at the Vantage Point

May 04, 2016

From the Editor

36

5

The Boston biotech cluster proved an ideal setting for Pharm Exec's recent annual Editorial Advisory Board meeting, with the prevailing message that even the best environments for innovation require constant nurturing.

Country Report: France

May 01, 2016

Special Sponsored Section

36

5

while France remains a global force in the pharmaceutical, medical device, and vaccines fields-and continues to tout a solid manufacturing base and re-exportation culture-questions are arising over the long- term sustainability of the country’s healthcare system and its traditionally generous public health provisions.

Pharmaceutical Executive, May 2016 Issue (PDF)

May 01, 2016

Issue PDF

36

5

Click the title above to open the Pharmaceutical Executive May 2016 issue in an interactive PDF format.

Pharma Under Fire for Driving "Opioid Abuse Epidemic"

April 27, 2016

Column

36

5

Policymakers seek to limit prescribing while also encouraging innovative R&D.